학술논문
Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes
Document Type
Clinical report
Author
Steg, Philippe Gabriel; Mehta, Shamir R.; Pollack Charles V. Jr.; Bode, Christoph; Cohen, Marc; French, William J.; Hoekstra, James; Rao, Sunil V.; Ruzyllo, Witold; Ruiz-Nodar, Juan M.; Sabate, Manel; Widimsky, Petr; Kiss, Robert Gabor; Estrada, Jose Luis Navarro; Hod, Hanoch; Kerkar, Prafulla; Guneri, Sema; Sezer, Murat; Ruda, Mikhail; Nicolau, Jose Carlos; Cavallini, Claudio; Ebrahim, Iftikhar; Petrov, Ivo; Jae-Hyung Kim; Myung-Ho Jeong; Lopez, Gabriel Arturo Ramos; Laanmets, Peep; Kovar, Frantisek; Gaudin, Christophe; Fanouillere, Karen C.; Minini, Pascal; Hoffman, Elaine B.; Moryusef, Angele; Wiviott, Stephen D.; Sabatine, Marc S.
Source
JAMA, The Journal of the American Medical Association. Sept 18, 2013, Vol. 310 Issue 11, p1145, 11 p.
Subject
Language
English
ISSN
0098-7484
Abstract
The study aims to evaluate the efficacy and safety of otamixaban as against unfractionated heparin as a form of treatment for patients with ischemic events in non-ST-segment elevation acute coronary syndromes. The results indicate that otamixaban was not effective in reducing ischemic events and even increased bleeding.